Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Dr.Lal PathLabs IPO is a book build issue of ₹631.91 crores. The issue is entirely an offer for sale of 1.16 crore shares of ₹631.91 crore.
Dr.Lal PathLabs IPO bidding started from Dec 8, 2015 and ended on Dec 10, 2015. The shares got listed on BSE, NSE on Dec 23, 2015.
Dr.Lal PathLabs IPO price band is set at ₹550.00 per share . The lot size for an application is 20. The minimum amount of investment required by an retail is ₹10,800 (20 shares). The lot size investment for sNII is 19 lots (380 shares), amounting to ₹2,09,000, and for bNII, it is 91 lots (1,820 shares), amounting to ₹10,01,000.
Citigroup Global Markets India Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Dr.Lal PathLabs IPO RHP for detailed Information.
| IPO Date | December 8, 2015 to December 10, 2015 |
| Listing Date | December 23, 2015 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹540 to ₹550 per share |
| Issue Price Final | ₹550 per share |
| Lot Size | 20 Shares |
| Sale Type | Offer For Sale |
| Total Issue Size | 1,16,00,000 shares (aggregating up to ₹631.91 Cr) |
| Retail Discount | Rs 15.00 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 8,26,44,757 shares |
| Share Holding Post Issue | 8,26,44,757 shares |
Dr Lal PathLabs IPO offers total 1,16,00,000 shares. Out of which 58,00,000 (50.00%) allocated to QIB, 23,20,000 (20.00%) allocated to QIB, 17,40,000 (15.00%) allocated to NII, 40,60,000 (35.00%) allocated to RII and 34,80,000 (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 58,00,000 (50.00%) | NA |
| − Anchor Investor Shares Offered | 34,80,000 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 23,20,000 (20.00%) | NA |
| NII (HNI) Shares Offered | 17,40,000 (15.00%) | NA |
| Retail Shares Offered | 40,60,000 (35.00%) | 2,03,000 |
| Total Shares Offered | 1,16,00,000 (100.00%) |
Dr.Lal PathLabs IPO opens on December 8, 2015, and closes on December 10, 2015.
| IPO Open Date | Tue, Dec 8, 2015 |
| IPO Close Date | Thu, Dec 10, 2015 |
| Tentative Listing Date | Wed, Dec 23, 2015 |
| Cut-off time for UPI mandate confirmation | 5 PM on Thu, Dec 10, 2015 |
Investors can bid for a minimum of 20 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 20 | ₹11,000 |
| Retail (Max) | 18 | 360 | ₹1,98,000 |
| S-HNI (Min) | 19 | 380 | ₹2,09,000 |
| S-HNI (Max) | 90 | 1,800 | ₹9,90,000 |
| B-HNI (Min) | 91 | 1,820 | ₹10,01,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Dr. Lal PathLabs Limited is a Delhi based provider of diagnostic and related healthcare tests and services in India. Through its nationwide network, company offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.
Company has built a national network consisting of its National Reference Laboratory in New Delhi, 163 other clinical laboratories, 1,340 patient service centers and over 5,000 pickup points as of March 31, 2015.
Company's customers include individual patients, hospitals and other healthcare providers and corporate customers.
Highlights:
1. Company offers 3,368 diagnostic and related healthcare tests.
2. Company collected 21.8 million samples from 9.9 million patients in FY 2015.
3. Company is well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry.
4. Its centralized information technology platform fully integrates to it network and is scalable.
| Particulars | For the year/period ended (in Rs. Million) | |||
| 31 Mar 15 | 31 Mar 14 | 31 Mar 13 | 31 Mar 12 | |
| Total Income | 6,401.17 | 5,438.97 | 4,238.61 | 3,199.03 |
| Profit After Tax (PAT) | 879.69 | 739.53 | 488.75 | 410.09 |
| KPI | Values |
|---|---|
| RoNW | 27.85% |
The Company Dr.Lal PathLabs IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | To achieve the benefits of listing the Equity Shares on the Stock Exchanges |
[Dilip Davda] <p><strong>As this is the first company under consumer healthcare diagnosis services sector having established brand and has no listed peers to compare with, it may enjoy the benefit of first mover of the sector and hence may attract fancy of investors. Although it being an expensive offer, moderate investment for short to medium term may be considered.</strong></p> Read detail review...
| Listing Date | December 23, 2015 |
| BSE Script Code | 539524 |
| NSE Symbol | LALPATHLAB |
| ISIN | INE600L01024 |
| Final Issue Price | ₹550 per share |
| BSE Listing Group | B |
Dr.Lal PathLabs Ltd.
Eskay House 54,
Hanuman Road,
New Delhi 110 001, India
New Delhi, New Delhi
Phone: +91 11 3040 3210
Email: cs@lalpathlabs.com
Website: https://www.lalpathlabs.com/
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: drlal.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Dr.Lal PathLabs IPO is a main-board IPO of 1,16,00,000 equity shares of the face value of ₹10 aggregating up to ₹631.91 Crores. The issue is priced at ₹550 per share. The minimum order quantity is 20.
The IPO opens on December 8, 2015, and closes on December 10, 2015.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Dr.Lal PathLabs IPO using UPI as a payment gateway. Zerodha customers can apply in Dr.Lal PathLabs IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Dr.Lal PathLabs IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Dr.Lal PathLabs IPO opens on December 8, 2015 and closes on December 10, 2015.
Dr.Lal PathLabs IPO lot size is 20, and the minimum amount required for application is ₹11,000.
You can apply in Dr.Lal PathLabs IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Dr.Lal PathLabs IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Dr.Lal PathLabs IPO allotment status.
The Dr.Lal PathLabs IPO listing date is on Wednesday, December 23, 2015.
Useful Articles
RHP